Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
about
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes MellitusClinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetesPhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.Diabetes mellitus: The epidemic of the century.The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY studyZinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesGenetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyImpact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.Incidence of type 1 diabetes in age groups above 15 years: facts, hypothesis and prospects for future epidemiologic research.Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.HLA-DQ genotypes - but not immune markers - differ by ethnicity in patients with childhood onset type 1 diabetes residing in Belgium.Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes.Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.The effect of insulin intensification in children and young persons with Type 1 diabetes differs in relation to ethnic group; a prospective observational study.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescence.
P2860
Q26796516-18958A48-C039-4BA6-B58C-6DA399F019E0Q33995773-1848A87F-2AC3-4B7F-8901-3317A86E6FD2Q34393377-24307574-EC39-4311-9B12-BFA6BE157EBDQ34623840-787DBEF7-039F-4A91-A8E0-54820E7FA75FQ34671155-BAD6A5C5-2ABB-47DB-BE24-65865C1CB788Q35371094-144D9FC4-B8B0-49C8-AE73-590BC9845EE3Q35976503-8A6E06D0-9D6A-4573-83C6-29D041C0C279Q36013572-BFAE6AC2-3E06-4CAD-AE96-02AF601C7C1FQ36047531-430C2D2D-3A82-4DA0-B49D-89658D41ED35Q36092708-28DBEE41-534C-45C2-8C8F-8FE95037229BQ36249785-D7132F5E-B9DA-4035-857B-AA0AD3470CE4Q38365047-29CC3CD8-E21C-49AA-934F-187A9DB13766Q38703570-20638743-5267-4E34-A72B-D47896978A32Q40944599-A90E8FEB-D0F7-414A-B5D4-54C0A0A8A64FQ41621457-0D484ACC-F76B-4F1A-90CB-712585DF705DQ44713976-85BD5BEB-88CF-41BF-9BF6-92400173286AQ46115645-5D424DFF-9158-4147-8D9B-252A36DC992BQ46232204-0B679943-D65E-47A9-81F7-570521FE7B4AQ47763684-43375CCE-E97D-4233-9952-1EC1EB9AAD3AQ47994233-1DE63F6F-B5EA-4AE3-8939-54747CD0B7E3Q51780438-D5C39EFF-816B-4148-A431-6CD406AC54C0
P2860
Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Contribution of antibodies aga ...... agnosed under 40 years of age.
@ast
Contribution of antibodies aga ...... agnosed under 40 years of age.
@en
type
label
Contribution of antibodies aga ...... agnosed under 40 years of age.
@ast
Contribution of antibodies aga ...... agnosed under 40 years of age.
@en
prefLabel
Contribution of antibodies aga ...... agnosed under 40 years of age.
@ast
Contribution of antibodies aga ...... agnosed under 40 years of age.
@en
P2093
P2860
P356
P1433
P1476
Contribution of antibodies aga ...... agnosed under 40 years of age.
@en
P2093
Bart Keymeulen
Belgian Diabetes Registry
Daniel G Pipeleers
Frans K Gorus
Ilse Vermeulen
Ilse Weets
Janet M Wenzlau
Johannes Ruige
John C Hutton
Luc Van Gaal
P2860
P304
P356
10.2337/DC10-2268
P407
P577
2011-06-29T00:00:00Z